Farrell, B;
Black, C;
Thompson, W;
McCarthy, L;
Rojas-Fernandez, C;
Lochnan, H;
Shamji, S;
Upshur, R;
Bouchard, M;
Welch, V.
OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline de...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabète de type 2,
Diabète,
Marqueurs biologiques/sang,
Glycémie/métabolisme,
Angiopathies diabétiques/prévention et contrôle,
Fructosamine/sang,
Hémoglobine glyquée/métabolisme,
Hypoglycémiants/usage thérapeutique,
Espérance de vie,
Préférence des patients,
Soins centrés sur le patient,
Hémoglobine glyquée,
Hypoglycémiants
La Guía de Práctica Clínica (GPC) tiene como misión elaborar recomendaciones que sirvan de ayuda a los profesionales sanitarios del Sistema Nacional de Salud (SNS) en la toma de decisiones para el manejo de los lípidos como factor de Riesgo Cardiovascular. En esta GPC no se abordan los siguientes as...
Maladies cardiovasculaires/étiologie,
Régime alimentaire/effets indésirables,
Hydrates de carbone alimentaires/administration et posologie,
Métabolisme lipidique/physiologie,
Maladies cardiovasculaires/sang,
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique,
Exercice physique/physiologie,
Diabète/étiologie,
Hydrates de carbone alimentaires/effets indésirables,
Matières grasses alimentaires/administration et posologie,
Matières grasses alimentaires/effets indésirables,
Dyslipidémies/étiologie,
Dyslipidémies/métabolisme,
Obésité/complications,
Obésité/prévention et contrôle,
Facteurs de risque,
Approche GRADE,
Lipides/sang,
Marqueurs biologiques/sang
Hingorani, A;
LaMuraglia, G. M;
Henke, P;
Meissner, M. H;
Loretz, L;
Zinszer, K. M;
Driver, V. R;
Frykberg, R;
Carman, T. L;
Marston, W;
Mills, J. L;
Murad, M. H.
Diabetes mellitus continues to grow in global prevalence and to consume an increasing amount of health care resources. One of the key areas of morbidity associated with diabetes is the diabetic foot. To improve the care of patients with diabetic foot and to provide an evidence-based multidisciplinary man...
Brindar recomendaciones para la práctica clínica, basados en la mejor evidencia disponible para la atención en salud y utilización racional de recursos para el diagnóstico, tratamiento y seguimiento ambulatorio de pacientes con diabetes mellitus tipo 1, en la población mayor de 15 años....
Brindar recomendaciones para la práctica clínica, basados en la mejor evidencia disponible para la atención en salud y utilización racional de recursos para el diagnóstico, tratamiento y seguimiento ambulatorio de pacientes con diabetes mellitus tipo 1, en la población mayor de 15 años....
OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
Evidence of benefits, harms, values and preferences, and cost effectiveness were reviewed in accordance with GRADE methods to determine the recommendation category (Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ; for the ACIP Evidence Based Recommendations Work Group (EBRWG). Methods for developing ...
Intersecting epidemics Tuberculosis (TB) remains a considerable global public health concern, mainly affecting poor and vulnerable populations. Every year, more than 9 million people fall ill with this infectious disease, and close to 2 million die from it. Diabetes, a chronic metabolic disease that is i...
This report is an addendum to the diagnostic criteria published in the 2006 WHO/IDF report “Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia” , and addresses the use of HbA1c in diagnosing diabetes mellitus. The WHO Consultation concluded that HbA1c can be used as a diag...
